Keywords: Mesenchymal-epithelial transition alteration, Synchronous non-small cell lung cancer, Capmatinib, Targeted therapy Lung cancer represents the leading cause of cancer-related deaths worldwide [1]. There are two main histological subtypes: non-small cell lung cancer (NSCLC) that accounts for roughly 80–85% of all the cases and small cell lung cancer that accounts for 15–20% [2].
Rey Cobo
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Rey
Contact Rey, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack